Key Insights

Highlights

Success Rate

100% trial completion (above average)

Related Conditions

Often studied with 6 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT02984280Completed

Specific Respiratory Infections as Triggers of Acute Medical Events

Showing all 1 trials

Research Network

Active Sponsors

  • University College, London1
  • Public Health England1

Top Investigators

Related Conditions

  • Influenza Human1
  • Cardiovascular Diseases1
  • Parainfluenza1
  • Rhinovirus1
  • Adenovirus1

Activity Timeline